Abstract
Osteoarthritis (OA) is nowadays the most common musculoskeletal progressive condition. In recent decades, incidence and prevalence of OA have increased significantly. It is estimated that the prevalence of OA among adults older than 60 is 12%, affecting about 240 million people globally. The cause has not been fully elucidated, and therefore, there is no cure at the moment. It is a multifactorial degenerative disease with an inflammatory component mediated by numerous proinflammatory and anti-inflammatory cytokines, chemokines, and growth factors. OA is not yet fully understood; therefore, therapeutic interventions are aimed primarily at reducing symptoms and slowing the progression of joint destruction. Of the therapeutic options available, the most often prescribed are nonsteroidal antirheumatic drugs, which have numerous side effects. Therefore, a need for a safe, effective substance is differentiated, which will be used in adjuvant treatment, but also in disease prevention, and which will comparatively have no or fewer side effects. One such substance is curcumin, a hydrophobic polyphenol that forms the active component of the rhizome of the Curcuma longa plant. Several studies have shown its potent antioxidant and anti-inflammatory effect, non-toxicity, and safety at high daily doses. In addition to blocking chondrocyte apoptosis, curcumin also blocks the expression of cyclooxygenase, prostaglandin E-2 and proinflammatory cytokines in chondrocytes, potentially alleviating symptomatic diseases. Although there are significant variations in quality, methodology, and research results conducted on curcumin efficiency in OA treatment, curcumin is primarily recommended as systematic short-term and medium-term adjuvant therapy that reduces inflammatory biochemical factors. Reducing inflammation leads to better pain regulation and improved joint function, significantly reducing standard prescribed doses of drugs. The most researched daily doses of curcumin intake are 1000–2000 mg/day, which would also be the doses that most of the authors recommend. Further research is needed to determine the preventive role of curcumin in the pathogenesis of OA, the effects of long-term usage of curcumin in preventive purposes and treatment of osteoarthritis, as well as to determine optimal therapeutic dosages.
Similar content being viewed by others
References
Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ (2018) Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med 52(3):167–175. https://doi.org/10.1136/bjsports-2016-097333
Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (2010) OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic, cumulative update of research published through January 2009. Osteoarthritis Cartil 18(4):476–499. https://doi.org/10.1016/j.joca.2010.01.013
Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF (2000) Osteoarthritis: new insights Part 1: the disease and its risk factors. Ann Intern Med 133(8):635–646. https://doi.org/10.7326/0003-4819-133-8-200010170-00016
Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl AJ, Pelletier JP (2016) Osteoarthritis. Nat Rev Dis Primers 2:16072. https://doi.org/10.1038/nrdp.2016.72
Ljuban N, Perić P (2017) Novi koncepti u patofiziologiji i liječenju osteoartritisa (new concepts in the pathophysiology and treatment of ostaoarthritis). Reumatizam 64(1):10–21
Greene MA, Loeser RF (2015) Aging-related inflammation in osteoarthritis. Osteoarthritis Cartil 23(11):1966–1971. https://doi.org/10.1016/j.joca.2015.01.008
Rogers EL, Reynard LN, Loughlin J (2015) The role of inflammation-related genes in osteoarthritis. Osteoarthritis Cartil 23(11):1933–1938. https://doi.org/10.1016/j.joca.2015.01.003
Liu-Bryan R (2015) Inflammation and intracellular metabolism: new targets in OA. Osteoarthritis Cartil 23(11):1835–1842. https://doi.org/10.1016/j.joca.2014.12.016
Daghestani HN, Kraus VB (2015) Inflammatory biomarkers in osteoarthritis. Osteoarthritis Cartil 23(11):1890–1896. https://doi.org/10.1016/j.joca.2015.02.009
Bowles RD, Mata BA, Bell RD, Mwangi TK, Huebner JL, Kraus VB, Setton LA (2014) In vivo luminescence imaging of NF-kappaB activity and serum cytokine levels predict pain sensitivities in a rodent model of osteoarthritis. Arthritis Rheumatol 66(3):637–646
Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A (2017) Phytosomal curcumin: a review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother 85:102–112. https://doi.org/10.1016/j.biopha.2016.11.098
Ameye LG, Chee WS (2006) Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 8(4):R127. https://doi.org/10.1186/ar2016
Hewlings SJ, Kalman DS (2017) Curcumin: a review of its effects on human health. Foods 6(10):92. https://doi.org/10.3390/foods6100092
Goulart M, Partar D, Cunha L, Zung S (2019) AB0792 curcumin in osteoarthritis treatment: the present state of evidence. Ann Rheum Dis 78:1867. https://doi.org/10.1136/annrheumdis-2019-eular.5744
Mathy-Hartert M, Jacquemond-Collet I, Priem F, Sanchez C, Lambert C, Henrotin Y (2009) Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res 58(12):899–908. https://doi.org/10.1007/s00011-009-0063-1
Grazio S, Schnurrer-Luke-Vrbanić T, Grubišić F, Kadoić M, Laktašić Žerjavić N, Bobek D, Vlak T (2015) Smjernice za liječenje bolesnika s osteoartritisom kuka i/ili koljena. Fiz rehabil med 27(3–4):330–381
Fernandes L, Hagen KB, Bijlsma JW et al (2013) European league against rheumatism (EULAR). EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 72(7):1125–1135. https://doi.org/10.1136/annrheumdis-2012-202745
Grazio S (2015) Preporuke i smjernice za liječenje osteoartritisa. Reumatizam 62(1):36–45
Doherty M, Abhishek A, Leeb B, Bijlsma JWJ (2012) European league against Rheumatism. EULAR textbook on rheumatic diseases: osteoarthritis, 1st edn. London (UK), BMJ Group
Grazio S (2007) Nefarmakološko liječenje mišićnokoštane boli. Reumatizam 54(2):37–48
Kolasinski SL, Neogi T, Hochberg MC et al (2020) 2019 American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 72(2):149–162. https://doi.org/10.1002/acr.24131
Cameron MH (2003) Physical agents from research to practice, 2nd edn. Saunders, St. Louis (MO), pp 185–224
Prince N, Penatzer JA, Dietz MJ, Boyd JW (2020) Localized cytokine responses to total knee arthroplasty and total knee revision complications. J Transl Med 18(1):330. https://doi.org/10.1186/s12967-020-02510-w
Appelboom T, Maes N, Albert A (2014) A new curcuma extract (flexofytol®) in osteoarthritis: results from a belgian real-life experience. Open Rheumatol J 8:77–81. https://doi.org/10.2174/1874312901408010077
Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A (2014) Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother Res 28(11):1625–1631. https://doi.org/10.1002/ptr.5174
Sahebkar A, Henrotin Y (2016) Analgesic efficacy and safety of curcuminoids in clinical practice: a systematic review and meta-analysis of randomized controlled trials. Pain Med 17(6):1192–1202. https://doi.org/10.1093/pm/pnv024
Bannuru RR, Osani MC, Al-Eid F, Wang C (2018) Efficacy of curcumin and Boswellia for knee osteoarthritis: systematic review and meta-analysis. Semin Arthritis Rheum 48(3):416–429. https://doi.org/10.1016/j.semarthrit.2018.03.001
Henrotin Y, Malaise M, Wittoek R, de Vlam K, Brasseur JP, Luyten FP, Jiangang Q, Van den Berghe M, Uhoda R, Bentin J, De Vroey T, Erpicum L, Donneau AF, Dierckxsens Y (2019) Bio-optimized curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study. Arthritis Res Ther 21(1):179. https://doi.org/10.1186/s13075-019-1960-5
Perkins K, Sahy W, Beckett RD (2017) Efficacy of curcuma for treatment of osteoarthritis. J Evid Based Complementary Altern Med 22(1):156–165. https://doi.org/10.1177/2156587216636747
Daily JW, Yang M, Park S (2016) Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food 19(8):717–729. https://doi.org/10.1089/jmf.2016.3705
Zeng L, Yu G, Hao W, Yang K, Chen H (2021) The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis. Biosci Rep 41(6):BSR20210817
Wu J, Lv M, Zhou Y (2019) Efficacy and side effect of curcumin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials. Pak J Pharm Sci 32(1):43–51
Chen W, Shi H, Deng P, Yang Z, Liu W, Qi L, Dong C, Si G, Guo D, Wang L (2022) Quality of evidence supporting the role of curcuma longa extract/curcumin for the treatment of osteoarthritis: an overview of systematic reviews. Evid Based Complement Alternat Med 2022:6159874. https://doi.org/10.1155/2022/6159874
Wang Z, Singh A, Jones G, Winzenberg T, Ding C, Chopra A, Das S, Danda D, Laslett L, Antony B (2021) Efficacy and safety of turmeric extracts for the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomised controlled trials. Curr Rheumatol Rep 23(2):11. https://doi.org/10.1007/s11926-020-00975-8
Nakagawa Y, Mori K, Yamada S, Mukai S, Hirose A, Nakamura R (2022) The oral administration of highly-bioavailable curcumin for one year has clinical and chondro-protective effects: a randomized, double-blinded, placebo-controlled prospective study. Arthrosc Sports Med Rehabil 4(2):e393–e402. https://doi.org/10.1016/j.asmr.2021.10.016
Shep D, Khanwelkar C, Gade P, Karad S (2019) Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study. Trials 20(1):214. https://doi.org/10.1186/s13063-019-3327-2
Wan Y, Sun W, Yang J, Ren J, Kou Q (2022) The comparison of curcuminoid formulations or its combination with conventional therapies versus conventional therapies alone for knee osteoarthritis. Clin Rheumatol 41(7):2153–2169. https://doi.org/10.1007/s10067-022-06105-2
Wang Z, Jones G, Winzenberg T, Cai G, Laslett LL, Aitken D, Hopper I, Singh A, Jones R, Fripp J, Ding C, Antony B (2020) Effectiveness of Curcuma longa EXTRACT for the treatment of symptoms and effusion-synovitis of knee osteoarthritis: a randomized trial. Ann Intern Med 173(11):861–869. https://doi.org/10.7326/M20-0990
Heidari-Beni M, Moravejolahkami AR, Gorgian P, Askari G, Tarrahi MJ, Bahreini-Esfahani N (2020) Herbal formulation “turmeric extract, black pepper, and ginger” versus Naproxen for chronic knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Phytother Res 34(8):2067–2073. https://doi.org/10.1002/ptr.6671
Hv S, Thomas JV, Vasavi HS, Shyamprasad K (2021) An open label, single arm, prospective clinical study to evaluate liver safety and tolerability of PUREMERIC™ (standardized extract from Curcuma longa) in healthy subjects. Toxicol Rep 8:1955–1959. https://doi.org/10.1016/j.toxrep.2021.11.022
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Koroljević, Z.D., Jordan, K., Ivković, J. et al. Curcuma as an anti-inflammatory component in treating osteoarthritis. Rheumatol Int 43, 589–616 (2023). https://doi.org/10.1007/s00296-022-05244-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-022-05244-8